4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4-DMAR, 4,4-dimethylaminorex): Availability, prevalence of use, desired effects and acute toxicity

Human Psychopharmacology

Volumn 30, Issue 3, 2015, Pages 193-198

  Glanville, James ^a   Dargan, Paul I ^a,b   Wood, David M ^a,b,c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

4 4 dimethylaminorex; novel psychoactive substance; recreational drugs; toxicity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 METHYL 5 (4 METHYLPHENYL) 4,5 DIHYDROOXAZOL 2 AMINE; 4 METHYLAMINOREX; 4' METHYLMETHCATHINONE; AMINOREX; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; OXAZOLE DERIVATIVE; PARA-METHYL-4-METHYLAMINOREX; STREET DRUG;

ACUTE TOXICITY; AMNESIA; ARTICLE; BRUXISM; DISEASE ASSOCIATION; DISEASE DURATION; DRUG BIOAVAILABILITY; DRUG COST; DRUG DETERMINATION; DRUG INDUCED DISEASE; DRUG USE; DYSPHORIA; HALLUCINATION; HEART ARRHYTHMIA; HEMIFACIAL SPASM; HUMAN; HYPERTHERMIA; INTERNET; LETHARGY; NAUSEA; PHARMACODYNAMICS; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; RESTLESS LEGS SYNDROME; SEROTONIN SYNDROME; SWEAT GLAND DISEASE; TACHYCARDIA; TREATMENT DURATION; XEROSTOMIA; ANIMAL; DOSE RESPONSE; SUBSTANCE-RELATED DISORDERS; SUPPLY AND DISTRIBUTION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERNET; OXAZOLES; PREVALENCE; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84928124602     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2472     Document Type: Article

References (34)

1. Bersani FS, Corazza O, Albano G, et al,. 2014. 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. Biomed Res Int 2014: 734749.
2. Bluelight 2014. Available from: http://www.bluelight.org (last accessed 10th August 2014).
3. Brandt SD, Baumann MH, Partilla JS, et al,. 2014, Characterization of a novel and potentially lethal designer drug, (±)-cis-para-methyl-4- methylaminorex (4,4-DMAR, or 'Serotoni'). Drug Test Anal 6: 684-695.
4. Chemsrus 2014. Available from: http://www.chemsrus.com (last accessed 10th August 2014).
5. Corazza O, Schifano F, Simonato P, et al,. 2012. Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine. Hum Psychopharmacol 27: 145-149. DOI: 10.1002/hup.1242.
6. Corkery JM, Elliott S, Schifano F, Corazza O, Ghodse AH,. 2012. 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): a preliminary review. Prog Neuropsychopharmacol Biol Psychiatry 39: 253-258. DOI: 10.1016/j.pnpbp.2012.05.021
7. Corkery JM, Elliott S, Schifano F, Corazza O, Ghodse AH,. 2013. MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update. Hum Psychopharmacol 28: 345-355. DOI: 10.1002/hup.2298
8. Cosbey S, Kirk S, McNaul M, et al,. 2014. Multiple fatalities involving a new designer drug: para-methyl-4-methylaminorex. J Anal Toxicol 38: 383-384. DOI: 10.1093/jat/bku031
9. Dargan PI, Sedefov R, Gallegos A, Wood DM,. 2011. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Test Anal 3: 454-463. DOI: 10.1002/dta.312
10. Drugs Forum 2014. Available from: http://www.drugs-forum.com (last accessed 10th August 2014).
11. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Action on new drugs. Available from: www.emcdda.europa.eu/activities/action-on-new-drugs (last accessed 15th August 2014).
12. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2011. Risk assessments: mephedrone. Available from: www.emcdda.europa.eu/attachements.cfm/att-116646-EN-TDAK11001ENC-WEB-OPTIMISED%20FILE.pdf (last accessed 30th January 2015).
13. European Monitoring Centre for Drugs and Drug Addiction 2014. European drug report: trends and developments. Available from: www.emcdda.europa.eu/attachements.cfm/att-228272-EN-TDAT14001ENN.pdf (last accessed 30th January 2015).
14. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2014. Risk assessments: 4-methylamphetamine (4-MA). Available from: www.emcdda.europa.eu/attachements.cfm/att-222680-EN-TDAK13001ENN-.pdf (last accessed 30th January 2015).
15. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol. 2014. EMCDDA-Europol Joint Report on a new psychoactive substance: 4,4-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine). Available from: www.emcdda.europa.eu/publications/joint-reports/4-4-DMAR (last accessed 30th January 2015)
16. Goeg 2014. Available from: https://forum.goeg.at (last accessed 10th August 2014).
17. Greenberg A,. 2013. 'Silk Road 2.0' launches, promising a resurrected black market for the dark web. Available from: http://www.forbes.com/sites/andygreenberg/2013/11/06/silk-road-2-0-launches-promising-a-resurrected-black-market-for-the-dark-web/ (last accessed 15th August 2014).
18. Gurtner HP,. 1985. Aminorex and pulmonary hypertension. A review Cor Vasa 27: 160-171.
19. Hillebrand J, Olszewski D, Sedefov R,. 2010. Legal highs on the Internet. Subst Use Misuse 45: 330-340.
20. Jerry J, Collins G, Streem D,. 2013. Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon. Cleve Clin J Med 79: 258-264.
21. Kilpatrick C,. 2014. Paramilitaries peddle 'serial killer' drug: unregulated stimulant para-methyl-4-methylaminorex sold for £2. Belfast telegraph. Available from: http://www.belfasttelegraph.co.uk/news/local-national/northern-ireland/paramilitaries-peddle-serial-killer-drug-unregulated-stimulant-paramethyl4methylaminorex-sold-for-2-30333433.html (last accessed 30th January 2015)
22. Measham F, Moore K, Newcombe R, Welch Z,. 2010. Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition. Drugs Alcohol Today 10: 14-21.
23. Nizar H, Dargan PI, Wood DM,. 2014. Using Internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance 4-methylaminorex and 4,4-dimethylaminorex. J Med Toxicol Epub ahead of print 29 Aug 2014. DOI: 10.1007/s13181-014-0425-0
24. Reddit (2014) Available from: http://www.reddit.com (last accessed 10th August 2014).
25. Sacco LN, Finklea K,. 2013. Synthetic drugs: overview and issues for Congress. Congressional Research Service Report for Congress. USA.
26. Serotonini.info 2014 Available from: http://www.serotoni.info (last accessed 10th August 2014).
27. Spiller HA, Ryan ML, Weston RG, Jansen J,. 2011. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin Toxicol (Phila) 49: 499-505. DOI: 10.3109/15563650.2011.590812
28. Ukchemicalresearch 2014 Available from: http://www.ukchemicalresearch.org (last accessed 10th August 2014).
29. United Nations Office on Drugs and Crime (UNODC) 2013. The challenge of new psychoactive substances. Available from: http://www.unodc.org/documents/scientific/NPS-2013-SMART.pdf (last accessed 30th January 2015).
30. Vermette-Marcotte A-E, Dargan PI, Archer JRH, Gosselin S, Wood DM,. 2014. An Internet snapshot study to compare the international availability of the novel psychoactive substance methiopropamine. Clin Toxicol (Phila) 52: 678-681. DOI: 10.3109/15563650.2014.933346
31. Wood DM, Davies S, Puchnaewicz M, et al,. 2010. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 6: 327-330. DOI: 10.1007/s13181-010-0018-5
32. Wood DM, Dargan PI,. 2012a. Novel psychoactive substances: how to understand the toxicity (harm) associated with the use of these substances. Ther Drug Monit 34: 363-367. DOI10.1097/FTD.0b013e31825b954b
33. Wood DM, Dargan PI,. 2012b. Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs. J Med Toxicol 8: 300-303. DOI: 10.1007/s13181-012-0241-3
34. Wood DM, Dargan PI,. 2012c. Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP). Clin Toxicol (Phila) 50: 727-732. DOI: 10.3109/15563650.2012.716158